Does folate deficiency cause macrocytosis?

The link between folate deficiency and macrocytosis is well-established, driven by a specific failure in DNA replication within red blood cell precursors. While this mechanism is a cornerstone of hematology, its clinical presentation can be complex, especially in older adults where multiple factors often overlap.

Clinical and diagnostic evidence

Folate deficiency is a primary cause of macrocytosis, typically characterized by a Mean Corpuscular Volume (MCV) exceeding 100 fL. However, research indicates that the diagnostic utility of MCV for identifying folate deficiency has limitations:

• Sensitivity and Specificity: In elderly populations, macrocytosis is often absent in the early stages of folate deficiency. Conversely, other common conditions in this age group—such as vitamin B12 deficiency, alcohol use, myelodysplastic syndromes (MDS), and certain medications—can also cause elevated MCV.
• Epidemiological Shifts: In regions with mandatory folic acid fortification, the prevalence of macrocytosis specifically caused by folate deficiency has declined, making other etiologies more likely in a clinical setting.

Mechanistic explanations

The transition from folate deficiency to macrocytic red blood cells occurs through a precise sequence of metabolic failures:

• The One-Carbon Bottleneck: Folate is essential for generating 5,10-methylene-tetrahydrofolate, the methylene donor required by the enzyme thymidylate synthase. When folate levels are low, this enzyme cannot efficiently convert deoxyuridine monophosphate (dUMP) into deoxythymidine monophosphate (dTMP).
• DNA Replication Stress: The resulting shortage of thymidine leads to a nucleotide imbalance. DNA polymerases erroneously incorporate uracil into the DNA strand in place of thymine. This triggers a "futile repair cycle" where DNA repair enzymes constantly remove uracil, leading to fragmented DNA and stalled replication forks.
• Nuclear-Cytoplasmic Asynchrony: While the cell cycle stalls in the S-phase due to impaired DNA synthesis, the cytoplasm continues to grow and accumulate hemoglobin. This decoupling of maturation processes results in the oversized, megaloblastic appearance of red blood cell precursors (erythroblasts), which eventually enter circulation as macrocytes.
• Mitochondrial Impact: Emerging evidence suggests that folate depletion also compromises mitochondrial DNA (mtDNA) stability by reducing mitochondrial dTMP synthesis, further impairing the terminal maturation of red blood cells.

Clinical implications

For an older patient presenting with macrocytosis:

• Comprehensive Testing: It is critical to measure both folate and vitamin B12 levels, as the two deficiencies present identically on a standard blood count.
• Rule Out Masking: Concomitant iron deficiency can sometimes "normalize" the MCV, masking the macrocytosis that would otherwise signal a folate or B12 issue.
• Practical Context: Given the high proliferative demand of erythroid precursors, even mild reductions in folate availability can trigger the DNA damage responses that lead to enlarged cells.

Bottom line

Folate deficiency causes macrocytosis by creating a thymidylate bottleneck that disrupts DNA synthesis, leading to replication stress and nuclear-cytoplasmic asynchrony. While pathophysiologically certain, the clinical diagnosis in older adults requires ruling out B12 deficiency and other age-related bone marrow conditions.